• Explore /
  • Poster
  • / Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.

Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.

Abstract Poster

Authors

Volker Budach

Volker Budach

Department of Radiooncology CCM/CVK, Charite University Medicine, Berlin, Germany

Volker Budach , Chie-Hee Cho , Benedikt Sedlmaier , Michael Wittlinger , Heinrich Iro , Rita Engenhart-Cabillic , Matthias Hautmann , Juergen Strutz , Michael Flentje , Beatrix Hueltenschmidt , Lutz Moser , Martin Bleif , Wilfried Budach , Susanne Staar , Gerd Becker , Silke Tribius , Petra C. Feyer , Klaus Dieter Wernecke , Jochen Werner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Head and Neck Cancer

Clinical Trial Registration Number

04-02

Citation

J Clin Oncol 30, 2012 (suppl; abstr 5512)

DOI

10.1200/jco.2012.30.15_suppl.5512

Abstract #

5512

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Stuart J. Wong

First Author: J. J. Caudell

First Author: Nabiel Ali Mir

First Author: Mohammad Jad Moussa